Skip to content

MRI evaluation of iron overload and therapeutic effect follow-up in thalassemia patients

MRI evaluation of iron overload and therapeutic effect follow-up in thalassemia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14004343
Enrollment
Unknown
Registered
2014-03-06
Start date
2014-03-10
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thalassemia

Interventions

Case group:MRI evaluation
Health volunteer group:Nil

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 25 Years

Inclusion criteria

Inclusion criteria: patients diagnosed heavy form of ßthalassemia with age between 2~25 years old

Exclusion criteria

Exclusion criteria: 1. patients with unstable vital sign or by other physiological or mental reasons can not undergo MRI exam; 2. relatives of the patient refuse to join this research; 3. patients with other diseases which can lead to iron overload; 4. patients with other diseases in liver or heart(ie. neoplasms); 5. patients have inflamation, liver disease, tumor,hemolysis or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
serum ferritin (SF);iron level of liver;iron level of Myocardium;

Secondary

MeasureTime frame
T2* scan of pancreas includes three parts of head, body and tail of pancreas.;The results of laboratory tests before and after the MRI T2* examination included fasting blood glucose, fasting insulin, pancreatic lipase and pancreatic amylase.;

Countries

China

Contacts

Public ContactLiang Biling

Sun Yat-sen Memorial Hospital

liangbl@163.net+86 13682205556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026